KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Times Interest Earned (2016 - 2025)

Historic Times Interest Earned for Pacira BioSciences (PCRX) over the last 16 years, with Q3 2025 value amounting to $1.49.

  • Pacira BioSciences' Times Interest Earned rose 10499.66% to $1.49 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.28, marking a year-over-year increase of 15363.99%. This contributed to the annual value of -$4.43 for FY2024, which is 20255.97% down from last year.
  • Pacira BioSciences' Times Interest Earned amounted to $1.49 in Q3 2025, which was up 10499.66% from $1.81 recorded in Q2 2025.
  • Pacira BioSciences' 5-year Times Interest Earned high stood at $10.32 for Q2 2023, and its period low was -$29.76 during Q3 2024.
  • For the 5-year period, Pacira BioSciences' Times Interest Earned averaged around $1.81, with its median value being $2.79 (2021).
  • Over the last 5 years, Pacira BioSciences' Times Interest Earned had its largest YoY gain of 133602.81% in 2024, and its largest YoY loss of 68165.8% in 2024.
  • Quarter analysis of 5 years shows Pacira BioSciences' Times Interest Earned stood at $0.4 in 2021, then crashed by 321.78% to -$0.9 in 2022, then skyrocketed by 1192.59% to $9.79 in 2023, then plummeted by 46.08% to $5.28 in 2024, then tumbled by 71.83% to $1.49 in 2025.
  • Its Times Interest Earned stands at $1.49 for Q3 2025, versus $1.81 for Q2 2025 and $0.43 for Q1 2025.